FindTrial
Sign In

Thrombelastography-Guided Blood Product Use In Cirrhosis With Severe Coagulopathy: A randomized controlled trial

Thrombelastography-Guided Blood Product Use In Cirrhosis With Severe Coagulopathy: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021442
Enrollment
Unknown
Registered
2019-02-21
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Cirrhosis

Interventions

Group A:The thrombelastogram guides transfusion
Group B:The coagulogram guides transfusion

Sponsors

Children’s Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged <18 years; 2. Patients diagnosed with cirrhosis complicated with coagulation dysfunction, who need a large number of blood transfusion products.

Exclusion criteria

Exclusion criteria: 1. Acute liver failure; 2. Anticoagulants are being used; 3. Hemophilia or other diseases of the blood system; 4. Participating in another blood transfusion related study.

Design outcomes

Primary

MeasureTime frame
the volume of blood product infusion;—

Secondary

MeasureTime frame
Bleeding occurs;A 90-day survival rate;—

Countries

China

Contacts

Public ContactChunbao Guo

Children’s Hospital of Chongqing Medical University

guochunbao@foxmail.com+86 13032386618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026